Your browser doesn't support javascript.
loading
Baseline Circulating Tumor Cell Count as a Prognostic Marker of PSA Response and Disease Progression in Metastatic Castrate-Sensitive Prostate Cancer (SWOG S1216).
Goldkorn, Amir; Tangen, Catherine; Plets, Melissa; Morrison, Gareth J; Cunha, Alexander; Xu, Tong; Pinski, Jacek K; Ingles, Sue A; Triche, Timothy; Harzstark, Andrea L; Kohli, Manish; MacVicar, Gary R; Vaena, Daniel A; Crispino, Anthony W; McConkey, David J; Lara, Primo N; Hussain, Maha H A; Quinn, David I; Vogelzang, Nicholas J; Thompson, Ian Murchie; Agarwal, Neeraj.
Afiliação
  • Goldkorn A; University of Southern California Norris Comprehensive Cancer Center and Keck School of Medicine, Los Angeles, California. agoldkor@med.usc.edu.
  • Tangen C; Statistics and Data Management Center at Fred Hutchinson Cancer Research Center, Seattle, Washington.
  • Plets M; Statistics and Data Management Center at Fred Hutchinson Cancer Research Center, Seattle, Washington.
  • Morrison GJ; University of Southern California Norris Comprehensive Cancer Center and Keck School of Medicine, Los Angeles, California.
  • Cunha A; University of Southern California Norris Comprehensive Cancer Center and Keck School of Medicine, Los Angeles, California.
  • Xu T; University of Southern California Norris Comprehensive Cancer Center and Keck School of Medicine, Los Angeles, California.
  • Pinski JK; University of Southern California Norris Comprehensive Cancer Center and Keck School of Medicine, Los Angeles, California.
  • Ingles SA; University of Southern California Norris Comprehensive Cancer Center and Keck School of Medicine, Los Angeles, California.
  • Triche T; University of Southern California Norris Comprehensive Cancer Center and Keck School of Medicine, Los Angeles, California.
  • Harzstark AL; Kaiser Permanente-Oakland, Oakland, California.
  • Kohli M; University of Utah Huntsman Cancer Institute, Salt Lake City, Utah.
  • MacVicar GR; Illinois Cancer Care/Heartland NCORP, Peoria, Illinois.
  • Vaena DA; West Cancer Center and Research Institute, Germantown, Tennessee, and University of Iowa, Iowa City, Iowa.
  • Crispino AW; UsTOO Las Vegas, Las Vegas, Nevada.
  • McConkey DJ; Johns Hopkins Greenberg Bladder Cancer Institute, Baltimore, Maryland.
  • Lara PN; UC Davis Comprehensive Cancer Center, Sacramento, California.
  • Hussain MHA; Northwestern University, Chicago, Illinois.
  • Quinn DI; University of Southern California Norris Comprehensive Cancer Center and Keck School of Medicine, Los Angeles, California.
  • Vogelzang NJ; Comprehensive Cancer Centers of Nevada, Las Vegas, Nevada.
  • Thompson IM; Christus Santa Rosa Hospital-Medical Center, San Antonio, Texas.
  • Agarwal N; University of Utah Huntsman Cancer Institute, Salt Lake City, Utah.
Clin Cancer Res ; 27(7): 1967-1973, 2021 04 01.
Article em En | MEDLINE | ID: mdl-33500355
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Antígeno Prostático Específico / Neoplasias de Próstata Resistentes à Castração / Células Neoplásicas Circulantes Tipo de estudo: Clinical_trials / Diagnostic_studies / Observational_studies / Prognostic_studies Limite: Adult / Aged / Aged80 / Humans / Male / Middle aged Idioma: En Revista: Clin Cancer Res Assunto da revista: NEOPLASIAS Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Antígeno Prostático Específico / Neoplasias de Próstata Resistentes à Castração / Células Neoplásicas Circulantes Tipo de estudo: Clinical_trials / Diagnostic_studies / Observational_studies / Prognostic_studies Limite: Adult / Aged / Aged80 / Humans / Male / Middle aged Idioma: En Revista: Clin Cancer Res Assunto da revista: NEOPLASIAS Ano de publicação: 2021 Tipo de documento: Article